We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Zosano Pharma Corporation in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less capital invested

Capital invested by funds: $62K → $0 (-$62K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CDIA
Capital Directions Investment Advisors
Georgia
-$38K
2
ACM
Aisling Capital Management
New York
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Aisling Capital Management
New York
– -$24K -77,663 Closed
CDIA
2
Capital Directions Investment Advisors
Georgia
– -$38K -103 Closed

ZSAN Hedge Fund Activity: Q3 2022 in Review

1 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2022, worth a combined $0 — down 100% from $62K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ZSAN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Capital Directions Investment Advisors, exiting entirely with an estimated $38K sold.

  • 1 institutional investor held Zosano Pharma Corporation (ZSAN) as of Q3 2022, down from 3 in Q2 2022.
  • Funds reported $0 of Zosano Pharma Corporation stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Zosano Pharma Corporation positions in Q3 2022 and 2 closed out, a net change of -2 holders.
  • The largest Zosano Pharma Corporation seller in Q3 2022 was Capital Directions Investment Advisors, an estimated $38K sold.

Based on aggregated 13F filings for Q3 2022.